pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
QL1706 (bispecific antibody targeting PD-1 and CLTA-4)
Phase 2 · small molecule · Esophageal Squamous Cell Carcinoma (ESCC)
QL1706 (bispecific antibody targeting PD-1 and CLTA-4) for Esophageal Squamous Cell Carcinoma (ESCC) is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code QLMA-EC-IIT-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- active
- Trials
- 1